tirzepatide week 4 weight loss percentage weight-loss study shows promising results Week 4 of Tirzepatide! 1
Description
Store tirzepatide pens in the refrigerator between 36F and 46F (2C to 8C)
18.2% average weight loss at week 68 was observed in patients in the STEP 4 trial, along with reduced blood glucose levels, improved lipid profile and significant improvements in overall quality of life and health status scores

the weight management indication for adults was added in November 2023
Patients may administer tirzepatide, with or without meals, any time of day, into the abdomen, upper thigh, or buttock

The injection for weight loss medication must be administered using the following method: Inject your dose of medication under the skin (subcutaneous injection) in your stomach area (abdomen), upper leg (thigh), If you want to use Mounjaro to lose weight, you need to inject the dose once a week at the same time and on the same day

Stimola la produzione di insulina
